person · Reporting owner
LLOYD JONES JONATHAN BRIAN
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PALISADE BIO, INC.CUR · Entity 5803 | Chief Financial Officer | March 24, 2017 | March 27, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PALISADE BIO, INC.
Report date March 24, 2017 · Filed March 27, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,859 |
Reported balance
After 2017-03-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-03-24 · Purchase · Acquired 5,455 · Balance 7,859 F1: Reporting person, Jonathan Lloyd Jones, purchased 5,455 shares of common stock in a private transaction directly from the issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Reporting person, Jonathan Lloyd Jones, purchased 5,455 shares of common stock in a private transaction directly from the issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 24, 2017 Filed Mar 27, 2017 20:06 UTC | PALISADE BIO, INC. CUR · Entity 5803 | PurchaseCommon Stock | 5,455 | $5.50 | $30,002.50 |
DisclosureSEC source: 0001171843-17-001771 · formfour.xml · nonDerivative · entry 1 LLOYD JONES JONATHAN BRIAN · CIK 0001567657 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,859 F1 · security: Reporting person, Jonathan Lloyd Jones, purchased 5,455 shares of common stock in a private transaction directly from the issuer. Read SEC document |
| September 23, 2016 Filed Sep 26, 2016 20:51 UTC | PALISADE BIO, INC. CUR · Entity 5803 | PurchaseCommon Stock | 31,250 | $0.32 | $10,000.00 |
DisclosureSEC source: 0001171843-16-012275 · formfour.xml · nonDerivative · entry 1 LLOYD JONES JONATHAN BRIAN · CIK 0001567657 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 F1 · security: Reporting person, Jonathan Lloyd Jones, purchased 31,250 shares of common stock in a private transaction directly from the issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.